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Abstract. 
 
Many cells express more than one integrin 
receptor for extracellular matrix, and in vivo these re-
ceptors may be simultaneously engaged. Ligation of 
one integrin may inﬂuence the behavior of others
on the cell, a phenomenon we have called integrin 
crosstalk. Ligation of the integrin 
 
a
 
v
 
b
 
3
 
 inhibits both
phagocytosis and migration mediated by 
 
a
 
5
 
b
 
1
 
 on the 
same cell, and the 
 
b
 
3
 
 cytoplasmic tail is necessary and 
sufﬁcient for this regulation of 
 
a
 
5
 
b
 
1
 
. Ligation of 
 
a
 
5
 
b
 
1
 
 
activates the calcium- and calmodulin-dependent pro-
tein kinase II (CamKII). This activation is required
for 
 
a
 
5
 
b
 
1
 
-mediated phagocytosis and migration. Simulta-
neous ligation of 
 
a
 
v
 
b
 
3
 
 or expression of a chimeric
molecule with a free 
 
b
 
3
 
 cytoplasmic tail prevents
 
a
 
5
 
b
 
1
 
-mediated activation of CamKII. Expression of a 
constitutively active CamKII restores 
 
a
 
5
 
b
 
1
 
 functions 
blocked by 
 
a
 
v
 
b
 
3
 
-initiated integrin crosstalk. Thus, 
 
a
 
v
 
b
 
3
 
 
inhibition of 
 
a
 
5
 
b
 
1
 
 activation of CamKII is required for 
its role in integrin crosstalk. Structure-function analysis 
of the 
 
b
 
3
 
 cytoplasmic tail demonstrates a requirement 
for Ser752 in 
 
b
 
3
 
-mediated suppression of CamKII acti-
vation, while crosstalk is independent of Tyr747 and
Tyr759, implicating Ser752, but not 
 
b
 
3
 
 tyrosine phos-
phorylation in initiation of the 
 
a
 
v
 
b
 
3
 
 signal for integrin 
crosstalk.
Key words: integrin • vitronectin • kinase • cross-
 
talk • signaling
 
D
 
YNAMIC
 
 interaction of cells with the complex pro-
tein mixtures found in the extracellular matrix oc-
curs during many biologic and pathologic pro-
cesses including development, wound healing, hemostasis,
metastasis, inflammation, and thrombosis (13, 18). Most
cells express multiple integrin receptors capable of inter-
action with the numerous ligands found in complex tissues.
The simultaneous ligation of multiple integrins mandates
coordination of the resulting signals. The coordination of
integrin signaling into a hierarchy with a net effect on cell
behavior has been called integrin crosstalk (2, 3, 17).
Numerous examples of integrin crosstalk have been re-
ported. The common theme of these reports lies in the reg-
ulation of the function of one integrin (the target) as a re-
sult of coligation of a second integrin (the transducer) on
the same cell. Examples of integrin crosstalk have been
demonstrated in numerous primary cell types and cell
lines including macrophages (2), T cells (17, 23), smooth
muscle cells (1), neutrophils (10), monocytes (15), umbili-
cal vein endothelial cells (20), malignant astrocytomas
(16), CHO cells (7, 9), K562 cells (2, 3), and embryonic
kidney 293 cells (20). Crosstalk may be initiated by trans-
ducing integrins belonging to the 
 
b
 
1
 
 (11, 15, 16, 22), 
 
b
 
2
 
 (17,
 
23), or 
 
b
 
3
 
 (1–3, 7, 9, 10, 20) family with targets in any
of these families as well. Integrin functions affected by
crosstalk include phagocytosis (2, 3, 10), soluble ligand
binding (7, 15), adhesion (9, 17, 23), migration (1, 17, 20),
gene expression (11), and receptor-mediated endocytosis
(16).
It is important to note that all reported cases of integrin
crosstalk are unidirectional, that is, ligation of the target
integrin does not affect the transducer integrin. In many
cases, the transducing integrin is much less highly ex-
pressed than the target integrin (2, 3). This suggests a hy-
pothesis that the receptor pairs involved in crosstalk are
not simply competing for interaction with a signaling mol-
ecule, but rather that ligation of the transducing integrin
initiates a unidirectional signaling cascade which affects
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the function of the target integrin. The molecular mecha-
nisms of integrin crosstalk remain undetermined. With a
single exception (20), crosstalk signals from the transduc-
ing integrin require the cytoplasmic tail of the 
 
b
 
-subunit,
and where it has been examined, the 
 
b
 
-subunit cytoplas-
mic tail has been sufficient for initiation of signaling (3).
We have previously described integrin crosstalk be-
tween 
 
a
 
v
 
b
 
3
 
 and 
 
a
 
5
 
b
 
1
 
 in macrophages and in a K562 cell
transfection model of macrophage integrins (2, 3). We
have shown that ligation of 
 
a
 
v
 
b
 
3
 
 inhibits 
 
a
 
5
 
b
 
1
 
-mediated
phagocytosis, which requires the high affinity state of the
integrin, without affecting 
 
a
 
5
 
b
 
1
 
-mediated adhesion, which
is independent of the high affinity state of the integrin.
The cytoplasmic tail of 
 
b
 
3
 
 is necessary and sufficient for
this crosstalk. 
 
a
 
v
 
b
 
3
 
-mediated inhibition of 
 
a
 
5
 
b
 
1
 
 phagocyto-
sis occurs at a step subsequent to 
 
a
 
5
 
b
 
1
 
 binding of ligand
and is reversed by H7, a pharmacologic inhibitor of serine/
threonine kinases.
In this report, we define a molecular mechanism re-
quired for 
 
a
 
v
 
b
 
3
 
-to-
 
a
 
5
 
b
 
1
 
 crosstalk. Ligation of 
 
a
 
5
 
b
 
1
 
 en-
hances the activity of the calcium/calmodulin-dependent
protein kinase II (CamKII)
 
1
 
. This increase in CamKII
activity is required for 
 
a
 
5
 
b
 
1
 
-dependent migration as well
as 
 
a
 
5
 
b
 
1
 
-dependent phagocytosis. Simultaneous ligation of
 
a
 
v
 
b
 
3
 
 inhibits 
 
a
 
5
 
b
 
1
 
 activation of CamKII activity, thus
blocking 
 
a
 
5
 
b
 
1
 
 migration and phagocytosis. Mutational
analysis of the 
 
b
 
3
 
 cytoplasmic tail demonstrates that
Ser752 is required for both 
 
a
 
v
 
b
 
3
 
-initiated inhibitory
crosstalk to 
 
a
 
5
 
b
 
1
 
 and 
 
a
 
v
 
b
 
3
 
 suppression of CamKII activity,
while tyrosine phosphorylation of the 
 
b
 
3
 
 cytoplasmic tail
has no effect on this activity. These results describe a po-
tential molecular pathway for integrin crosstalk that in-
volves integrin regulation of CamKII activity.
 
Materials and Methods
 
Cells and 
 
b
 
3
 
 cDNA Mutation
 
Human peripheral blood monocyte-derived macrophages were prepared
as previously described (2). The human erythroleukemic cell line K562
transfected with cDNA encoding 
 
a
 
v
 
b
 
3
 
 (K
 
a
 
v
 
b
 
3
 
), 
 
a
 
v
 
b
 
3
 
 in which the tyrosine
residue at position 747 or 759 was mutated to phenylalanine (K
 
a
 
v
 
b
 
3
 
Y747F
and K
 
a
 
v
 
b
 
3
 
Y759F, respectively) and Tac
 
b
 
3
 
 (chimera of the extracellular
and transmembrane domain of the IL2 receptor 
 
a
 
-chain [Tac subunit] and
the cytoplasmic tail of 
 
b
 
3
 
, KTac
 
b
 
3
 
) were derived and maintained as de-
scribed (2, 3). In addition K562 cells were similarly transfected with
cDNA encoding Tac
 
b
 
3
 
 in which the serine residue at position 752 was
replaced with proline (KTac
 
b
 
3
 
S-P), cysteine (KTac
 
b
 
3
 
S-C), alanine
(KTacb3S-A), or glutamic acid (KTacb3S-E). Expression of all Tacb3S-X
chimeras was equivalent to Tacb3 (3) as determined by flow cytometry as
described (2; see Table I). For construction of Tacb3S-X, the HindIII and
XhoI fragment of pTacb3 encoding the CT of b3 (3) was ligated into
HindIII-XhoI–digested pBluescript (Stratagene), creating pBSKSPB3-
TAIL. This contruct was subjected to PCR using a 59 T7 oligonucleotide
(Stratagene) with the 39 oligonucleotide (59-CCCCCCTCGAGTTA-
AGTGCCCCGGTACGTGATATTGGTGAAGGT-XXX-CGTGGC-39)
where XXX is AGG for S752P, ACA for S752C, GCT for S752A, and TTC
for S752E. The resulting products were digested with HindIII-XhoI and li-
gated into pTacb3 digested with HindIII-XhoI, creating pTacb3S-P,
pTacb3S-C, pTacb3S-A, and pTacb3S-E, respectively.
K562 cells also were transfected with full-length avb3 in which the
serine at position 752 of b3 was mutated to alanine as described for the
mutation of b3 tyrosine residues (4). In brief, nested PCR was performed
on pBLY100 using the overlapping oligonucleotides 59-GAGGCCAC-
GCCTACCTTCACCAATATCACG-39 and 59-CTCCGGTGCGGATG-
GAAGTGGTTATAGTGC-39 encoding the S-A mutation with oligonu-
cleotides in the mutation cassette (4). After the nested PCR reaction, the
wild-type b3 CT was replaced with the S-A mutant CT by NdeI-NheI re-
striction. Transfection, selection, and fluorescent cell sorting for expres-
sion levels of avb3S752A equivalent to wild-type avb3 was as described
previously, resulting in Kavb3S752A (Table I). Modified cDNAs were ver-
ified by dideoxy nucleotide sequencing.
Phagocytosis, Adhesion, and Migration
Phagocytosis assays were performed as described (2) by flow cytometry
using either FITC-FN– or FITC-mAb16 (anti-a5)–coated 3.0-mm beads.
Data are presented as a Phagocytic Index, the number of beads internal-
ized per 100 cells.
Chemotaxis assays were performed in modified Boyden chambers
(Neuroprobe) using 14.0-mM polycarbonate filters as described (19). Vi-
tronectin (VN), fibronectin (FN), and BSA were added to basal chambers
at 5 mg/ml and mAb at 10 mg/ml were added to apical chambers coincident
with cells. Cells in Iscove’s Modified Eagle’s Medium (IMDM) adjusted to
1 mM Ca21 and 1 mM Mg21 with 0.5% human serum albumin and 2.0 mM
Mn21Cl were incubated for 4 h at 378C in a humidified 5% CO2 atmo-
sphere for migration. Migration was quantitated by counting the number
of cells per high power field on the underside of the filter after Giemsa
staining.
Adhesion assays were performed as described in FN-coated (10 mg/ml)
microtiter wells (2). Data are presented as the percent of added cells ad-
herent after 1 h at 378C.
CamKII Activity Assay
Transfected K562 cells or monocyte-derived macrophages were stimu-
lated as described in the text, washed once by centrifugation in ice-cold
IMDM and suspended in ice-cold homgenization buffer containing Hepes
(50 mM), EDTA (4 mM), EGTA (2 mM), sucrose (0.25 M), dithiothreitol
(1 mM), phenylmethylsulfonyl fluoride (0.2 mM), Na3VO4 (2.0 mM), NaF
(5.0 mM), phenyl-arsine-oxide (10.0 mM), and leupeptin (10 mg/ml), pH
7.5. Suspended cells were sonicated on ice and assayed for CamKII activ-
ity against the synthetic substrate autocamtide II (KKALRRQETVDAL)
(21). An aliquot of cell extracts was used for protein determination by
BCA. Parallel aliquots were assayed for CamKII activity in a 25-ml reac-
tion mixture containing Hepes (50 mM), magnesium acetate (10 mM),
Na3VO4 (2.0 mM), NaF (5.0 mM), phenyl-arsine-oxide (10.0 mM), CaCl2
(1 mM), calmodulin (0.1 mM; Sigma Chemical Co.), autocamtide II (20 mM),
and g-[32P]ATP (0.1 mM, 3,000 cpm/pmol). The reaction was initiated by
ATP addition and terminated by addition of trichloroacetic acid to a final
concentration of 10%. The reaction mixture was centrifuged through
phosphocellulose separation units (Pierce) and washed as described (26).
CamKII activation results from phosphorylation events that result in ki-
nase activity which is no longer dependent upon exogenous calcium or
calmodulin. CamKII activity in cellular extracts was measured by quanti-
tating the incorporation of radioactive phosphate into a synthetic CamKII
1. Abbreviations used in this paper: CamKII, calcium/calmodulin-depen-
dent protein kinase II; FN, fibronectin; IMDM, Iscove’s Modified Eagle’s
Medium; LIBS, ligand-induced binding site; MLCK, myosin light chain ki-
nase; VN, vitronectin.
Table I. Integrin Expression in Transfected K562 Cells
P5D2
(b1)
AP3
(b3)
4E3
(Tac)
mAb16
(a5)
IC12
(av)
K562 9.83 0.37 0.42 13.2 0.22
Kavb3 10.1 29.2 0.44 13.0 31.4
Kavb3Y747F 9.99 29.7 0.44 12.8 30.9
Kavb3Y759F 9.87 30.0 0.37 13.1 29.7
Kavb3S752A 10.7 29.8 0.44 12.6 29.9
KTacb3 11.1 0.45 8.77 13.0 0.33
KTacb3S-P 10.5 0.57 9.32 13.3 0.34
KTacb3S-A 9.89 0.49 8.91 12.5 0.26
KTacb3S-E 11.0 0.57 9.74 12.8 0.29
KTacb3S-C 9.87 0.46 11.2 13.2 0.41
KTacb5 10.3 0.67 9.88 13.1 0.31Blystone et al. Integrin Crosstalk 891
substrate (autocamtide-2) in the presence (calcium/calmodulin-indepen-
dent 1 calcium/calmodulin-dependent activity) or absence (calcium/cal-
modulin-independent activity) of calcium and calmodulin. The activation
of CamKII (autonomous activity) is expressed as a direct percentage of
the total cellular CamKII activity (1) in which:
where autonomous activity equals the CamKII activity without calcium or
calmodulin and total activity equals CamKII activity with calcium or cal-
modulin.
CamKII expression levels in transfected cell lines was assessed by im-
munoprecipitation as previously described, followed by Western blot
analysis (1).
Infection of K562 Cells with Adenovirus Encoding 
Constitutively Active CamKII
Kavb3, KTacb3, and KTacb5 were infected with a replication defective
adenovirus in which the E1 region was replaced with the CMV early
promoter and the cDNA for a constitutively active CamKII (Ad-
CMV.CKIID3) or b-galactosidase (AdCMV.gal) and viral stocks prop-
agated and titered as described (1). Transfected K562 cells at 5 3 106/ml in
IMDM were infected with recombinant adenovirus at a multiplicity of in-
fection of 100 for 1 h followed by the addition of normal growth medium
to dilute cells to a concentration of 0.5 3 106/ml. After 4–6 h, cells were
harvested for analysis of CamKII activity or functional assay as described
in Results. Viability of all infected cell types exceeded 85% at the initia-
tion, and 70% at the conclusion of experimental time courses.
Proteins and Antibodies
FN was purified by gelatin affinity and VN by heparin affinity as previ-
ously described (2, 3). Monoclonal antibodies 7G2 (anti–human b3), W6/
32 (anti–human HLA), IC12 (anti–human av), AP3 (anti–human b3),
P1F6 (anti–human b5), 4E3 (anti-IL2Ra, gp55, TAC), and mAb16 (anti–
human a5) have been previously described and were used in excess at 5.0
mg/ml unless otherwise indicated (2, 3).
Reagents
The kinase inhibitors H7 (50 nM), KN62 (2.5 mM), KN04 (5.0 mM),
KT5926 (20 nM), and ML-9 (2 mM) were included in some assays where
indicated and all were from LC Laboratories (Woburn, MA). All other re-
agents were from Sigma Chemical Co. unless otherwise indicated.
Data Presentation
Data are presented as the mean 6 SEM from at least three replicates for
all studies. Significance was determined by analysis of variance followed
by Duncan’s comparison testing. A minimum confidence interval of 95%
was employed for all studies.
Results
avb3 Crosstalk Regulates a5b1-mediated Migration
We have previously described a phenomenon, termed in-
tegrin crosstalk, in which ligation of avb3 prevents a5b1-
mediated phagocytosis in macrophages and in K562 cells
expressing transfected avb3. To determine if integrin
crosstalk regulated a5b1 functions other than phagocytosis,
we evaluated the effects of avb3 ligation on the migration
of K562 cells on the a5b1 ligand FN. K562 cells did not mi-
grate specifically to FN in IMDM containing 1 mM Ca21
and 1 mM Mg21. However, addition of 2 mM Mn21 or the
a5b1 conformation-stabilizing mAbs 8A2 or A1A5 at 5.0
mg/ml greatly enhanced the FN-specific migration of these
cells, consistent with a requirement for high affinity a5b1
in migration (data not shown). As shown in Fig. 1 A, the
migration of untransfected K562 to FN in the presence of
% CamKII activity Autonomous activity 
Total activity
---------------------------------------------------- 100 ´ =
2 mM Mn21 was enhanced sixfold over migration to the
nonspecific protein casein; this migration was completely
inhibited by mAb to a5b1 (data not shown). We also exam-
ined  avb3-mediated migration in K562 expressing this
transfected integrin in addition to the endogenous a5b1.
Kavb3 migrated in response to VN (Fig. 1 A); migration
response to VN was inhibited by mAb to av or b3 (data not
shown). However, migration of Kavb3 to FN was severely
impaired compared with untransfected or mock trans-
fected K562 (Fig. 1 A). Migration of Kavb3 to FN was re-
stored by the addition of the ser/thr kinase inhibitor H7
(50 nM), while addition of H7 had no effect on Kavb3 mi-
gration to VN (data not shown). Restored migration of
Kavb3 to FN in the presence of H7 was completely inhib-
ited by mAb to b1 (data not shown). These results com-
pletely parallel the previously described avb3-mediated
crosstalk which inhibits a5b1-mediated phagocytosis (3)
and support the hypothesis that the coligation of avb3 by
FN regulates a5b1-mediated K562 cell migration to FN be-
Figure 1. avb3 crosstalk regulates a5b1-mediated migration. Un-
transfected K562 cells, Kavb3, KTacb3, and KTacb5 were permit-
ted to migrate to vitronectin (VN), fibronectin (Fn) or casein
through 14.0-mM pores in a modified Boyden chamber apparatus
as described in Materials and Methods (A). For structure-func-
tion analysis of integrin crosstalk, untransfected K562 cells and
K562 cells expressing transfected wild-type avb3 (Kavb3) or avb3
bearing single amino acid mutations Tyr747-Phe (Kavb3Y747F),
Tyr759-Phe (Kavb3Y759F) or Ser752-Ala (Kavb3S752A) were
assayed for migration to Fn, VN, or casein as described in Mate-
rials and Methods (B). Migration was quantitated manually by
counting cells adherent to the basal side of the filter and reported
as the number of cells per well. Shown are mean 6 SEM of four
determinations with no fewer than eight replicates.The Journal of Cell Biology, Volume 145, 1999 892
cause this function, like phagocytosis, requires a high af-
finity form of a5b1.
To demonstrate definitively that avb3 regulation of
a5b1-mediated migration was another example of integrin
crosstalk, we examined migration to FN in KTacb3 and
KTacb5, K562 cells expressing chimeric molecules com-
prised of the extracellular domain of the IL2 receptor and
the cytoplasmic tail domain of the b3 or b5 integrin, respec-
tively. Expression of Tacb3, but not Tacb5, leads to consti-
tutive inhibition of a5b1-mediated phagocytosis in K562
cells (3; see Fig. 7 B). Expression of Tacb3, but not Tacb5
(Fig. 1 A) or Tac lacking a cytoplasmic tail (KTacNT, Fig.
2 A), completely inhibited a5b1-mediated migration to FN.
The constitutive inhibition of migration to FN in KTacb3
was reversed by the addition of 50 nM H7 (Fig. 2 A).
These studies demonstrate that a5b1-mediated migration
and a5b1-mediated phagocytosis are similarly regulated by
avb3 or the isolated b3 CT and that this regulation is de-
pendent upon a ser/thr kinase regulated by H7. These data
suggest that both a5b1-mediated migration and a5b1-medi-
ated phagocytosis are regulated by avb3-initiated crosstalk.
b3 Ser752 Is Required for b3 Crosstalk
We have previously demonstrated that expression of the
isolated b3 cytoplasmic tail is sufficient for initiation of
avb3 crosstalk (Fig. 1 A and reference 12). To further de-
lineate the required sequence elements of this unique reg-
ulatory pathway, we introduced point mutations in the b3
cytoplasmic tail and analyzed their effects upon avb3-initi-
ated crosstalk to a5b1-mediated migration.
In a spontaneously occurring Glanzmann’s Thrombas-
thenia mutation, the serine residue at position 752 of the
b3 CT is mutated to proline (6). This mutation results in
loss of platelet b3 function and a severe bleeding disorder.
In vitro study has shown that Ser752 of the b3 CT is re-
quired for the conformational change associated with ele-
vated affinity of b3 for ligand (8). To test whether Ser752
also is required for integrin crosstalk, we expressed an
avb3 receptor in K562 cells in which Ser752 of b3 was mu-
tated to Ala (Fig. 1 B). While the ligation of wild-type avb3
blocked a5b1-mediated migration on FN (Fig. 1 B), the
S752A mutant migrated as well as the untransfected cells.
In addition, the S752A mutant migrated as well as wild-
type avb3 on VN (Fig. 1 B), consistent with reports that
this mutation does not affect ligand binding by b3 integrins
(8). This demonstrates that failure of the S752A mutant to
initiate crosstalk did not result from an inability to recog-
nize ligand.
Recently, a tyrosine in the b3 cytoplasmic tail, Tyr747,
has been implicated in activation-dependent avb3 adhe-
sion to VN (4). In contrast to the S752A mutation, Y747F
had no effect on avb3-initiated integrin crosstalk (Fig. 1 B).
Consistent with the previous report of a requirement for
this tyrosine in firm adhesion, the Y747F mutation did
abolish migration of Kavb3Y747F to VN (Fig. 1 B). Muta-
tion of Tyr759 to Phe (Y759F) did not affect either
crosstalk or the migration function of avb3. These data
demonstrate that the crosstalk signaling and adhesive
functions of avb3 have distinct and independent sequence
requirements in the b3 cytoplasmic tail.
To evaluate further the requirement for b3 S752 in inte-
grin crosstalk, additional mutations at that position were
made in the consititutively inhibitory Tacb3 construct. Mu-
tation of Ser752 to Glu, Pro, or Cys as well as Ala abol-
ished the inhibitory activity of Tacb3 on a5b1-dependent
migration (Fig. 2 A) and a5b1-dependent phagocytosis
(Fig. 2 B). Like the wild-type b3 cytoplasmic tail, none of
Figure 2. Role of b3 Ser752 in avb3 crosstalk. K562 cells trans-
fected with vector alone (Rc/RSV) or a chimeric molecule com-
posed of the extracellular and transmembrane domains of the
IL2 receptor (Tac) and the cytoplasmic tail of integrin subunits;
no tail (TacNT), b3 (Tacb3), b5 (Tacb5), or b3 in which Ser752
had been mutated to Pro (Tacb3S-P), Cys (Tacb3S-C), Ala
(Tacb3S-A), or Glu (Tacb3S-E) were evaluated for their ability to
migrate to FN (A), phagocytose FN opsonized beads (B), and ad-
here to FN-coated tissue culture plastic (C) as described in Mate-
rials and Methods. Parallel samples were treated with 50 nM H7
as indicated. Shown are mean 6 SEM of no fewer than three de-
terminations performed in triplicate.Blystone et al. Integrin Crosstalk 893
the mutants affected K562 binding to FN-coated surfaces,
a function that does not require the high affinity state of
a5b1 (Fig. 2 C). The addition of H7 reversed the Tacb3
inhibition of a5b1-mediated migration and phagocytosis
(Fig. 2, A and B).
a5b1 and avb3 Differentially Regulate CamKII
avb3 ligation inhibits the a5b1 high affinity functions of
phagocytosis and migration, without effect upon a5b1-
mediated adhesion. Alterations in a5b1 affinity can be reg-
ulated by calcineurin, a calcium/calmodulin-dependent
phosphatase and CamKII (calcium/calmodulin-dependent
protein kinase II; reference 1). Recently, inhibition of
CamKII activity by avb3 ligation in smooth muscle cells
was reported (1). Therefore, we evaluated avb3 regula-
tion of CamKII as a potential mediator of avb3-initiated
crosstalk.
CamKII activity was measured in human monocyte-
derived macrophages in the presence and absence of an
a5b1-specific phagocytosis target (mAb-16–coated latex
beads) (3). Ligation of macrophage a5b1 with mAb-16
beads enhanced CamKII activity twofold, while ligation
with a control target (W6/32 beads) had no effect (Fig. 3
A). Both basal and stimulated CamKII activities were de-
creased by the CamKII inhibitor KN62, but not the struc-
turally related, but non-inhibitory KN04. Ligation of avb3
with soluble mAb 7G2 prevented the rise in CamKII activ-
ity induced by mAb-16 beads (Fig. 3 A). No additional de-
crease in CamKII activity was detected when KN62 and
7G2 were combined. Thus, b3 ligation prevented the a5b1-
induced rise in CamKII activity.
To explore further the hypothesis that CamKII medi-
ates avb3 regulation of a5b1, we evaluated the regulation of
CamKII in Kavb3. Binding of mAb-16 beads to Kavb3, and
to vector-transfected K562 (data not shown), resulted in
an increase in CamKII activity (Fig. 3 B) that was not seen
when Kavb3 were incubated with W6/32 beads that bound
to the cells equivalently. As in macrophages, the a5b1-
mediated rise in CamKII activity was prevented by liga-
tion of avb3 with soluble mAb 7G2 (Fig. 3 B) and by 7G2
Fab fragments or Arg-Gly-Asp peptide (Fig. 3 D). As seen
in macrophages, inhibition of the a5b1-induced increase in
CamKII activity by avb3 ligation was blocked by KN62,
but not KN04.
Previously we have demonstrated that the cytoplasmic
tail of b3 is both necessary and sufficient for avb3 inhibi-
tory crosstalk to a5b1 (reference 3 and Fig. 2, A and B). In
the presence of mAb-16 beads, expression of Tacb3, but
not Tacb5, prevented the a5b1-mediated rise in CamKII
activity (Fig. 3 C). These results indicate that a5b1 and
avb3 differentially regulate CamKII activity in macro-
phages and K562 cells.
To determine if the failure of the Kavb3S752A to initiate
crosstalk was related to an inability to regulate CamKII,
we evaluated CamKII activity after mAb-16 bead binding
in K562 cells transfected with wild-type avb3 and the
S752A and Y747F mutants. While ligation of avb3 with the
Figure 3. Regulation of
CamKII activity by a5b1 and
avb3. Human monocyte-de-
rived macrophages (A) or
K562 cells expressing trans-
fected avb3 (Kavb3, B) or in-
tegrin  b5 (KTacb5) or b3
(KTacb3) cytoplasmic tail
chimeras (C) were assayed
for activity of the calcium-
and calmodulin-dependent
protein kinase II against a
synthetic substrate as de-
scribed in Materials and
Methods. Cells were either
left unstimulated (no beads)
or presented with control
phagocytosis targets (W6/32
beads) or with an a5b1-
specific phagocytosis target
(mAb-16 beads) in the pres-
ence and absence of KN62
(2.5  mM), KN04 (5.0 mM) or
5.0  mg/ml mAb 7G2 either
individually or in combina-
tions as indicated. D shows
the inhibition of CamKII
activity in Kavb3 after a5b1
ligation with mAb-16 beads
by soluble mAb 7G2 (5.0
mg/ml), 7G2 Fab9 (3.8 mg/ml), and 2.0 mM GRGDSP peptide and the lack of inhibition by mAb P1F6 or 2 mM GRGESP. Regulated
CamKII activity is presented as the percent of total activity as described in Materials and Methods. Shown are mean 6 SEM for no
fewer than three determinations in each group of all panels.The Journal of Cell Biology, Volume 145, 1999 894
b3-specific mAb 7G2 suppressed mAb-16 bead-induced
activation of CamKII, mutation of Ser752 of b3 prevented
the suppression of CamKII activity seen upon avb3 liga-
tion (Fig. 4 A). However, mutation of Tyr747 or Tyr759
(data not shown) did not affect avb3 regulation of CamKII.
Thus, Ser752 is required for both avb3 inhibitory crosstalk
to a5b1 (Fig. 2) and avb3 regulation of CamKII (Fig. 4).
To determine the effect of avb3 and mutant b3 on ex-
pression of CamKII, immunoprecipitates of CamKII were
analyzed by Western blot with CamKII-specific Ab. As
shown in Fig. 4 B, cellular expression of CamKII (see ar-
row) was unchanged by the expression of avb3 and mu-
tants in transfected K562 cells.
Role of CamKII in avb3 Crosstalk to a5b1
Suppression of the a5b1-dependent increase in CamKII ac-
tivity by avb3 ligation or by Tacb3 expression suggested
that CamKII regulation could have a role in avb3 crosstalk
Figure 4. Role of b3 Ser752 in avb3 regulation of CamKII. Un-
transfected K562 cells or K562 cells expressing transfected wild-
type avb3 (Kavb3) or avb3 in which Tyr747 was mutated to Phe
(Kavb3Y747F) or in which Ser752 was mutated to Ala
(Kavb3S752A) were assayed for CamKII activity (A) as de-
scribed in Materials and Methods, after a5b1 ligation with mAb-
16 beads in the presence or absence of the avb3 ligand 7G2 (5.0
mg/ml). Shown are mean 6 SEM of three determinations with no
fewer than three replicates. Also as described in Materials and
Methods, total cellular CamKII (see arrow) from transfected
K562 cell populations used in this study was recovered by immu-
noprecipitation and revealed by Western blotting (B). For un-
transfected K562 cells, cell lysates were cleared by immunopre-
cipitation with anti-CamKII twice (cleared 23) or once (cleared
13), before analysis of the final immunoprecipitation to ensure
that recovery of protein was complete. Shown is a representative
study.
Figure 5. Effects of CamKII inhibitors on a5b1 function and avb3
crosstalk. Phagocytosis of the a5b1-specific target mAb-16 beads,
or control target P1F6-beads was evaluated in K562 expressing
avb3 in the presence and absence of avb3 ligation by mAb 7G2
(5.0 mg/ml) and/or the CamKII inhibitor KN62 (2.5 mM) or con-
trol KN04 (5.0 mM) (A) as described in Materials and Methods.
Shown are mean 6 SEM of three determinations with four repli-
cates each. a5b1-mediated phagocytosis of FN beads was evalu-
ated in untransfected K562 cells in the presence and absence of
KN62 (2.5 mM), KN04 (5.0 mM), or the b3-specific mAb 7G2 (5.0
mg/ml) (B) as described in Materials and Methods. Shown are the
mean 6 SEM of two determinations with three replicates each.
In C, the migration of untransfected K562 cells, Kavb3, KTacb3,
and KTacb5 to FN was assessed in the presence and absence of
KN62 (2.5 mM) or KN04 (5.0 mM) as described in Materials and
Methods. Shown are mean 6 SEM of four determinations with at
least three replicates each.Blystone et al. Integrin Crosstalk 895
to a5b1. To determine the role of CamKII in avb3 crosstalk
to a5b1, Kavb3 cells were incubated with the a5b1 phagocy-
tosis target, mAb-16 beads, or control target, P1F6 (anti-
avb5) beads. Phagocytosis was measured in the presence
and absence of 7G2 to ligate avb3, the CamKII inhibitor
KN62, or control KN04. As reported previously, phagocy-
tosis via a5b1 was inhibited upon avb3 ligation with mAb
7G2 (2, 3). a5b1 phagocytosis also was inhibited by KN62
(Fig. 5 A), but not KN04. Combining 7G2 and KN62 re-
sulted in no further decrease in a5b1 phagocytosis. Under
all conditions, there was no significant internalization of
P1F6 beads.
To determine the dependence of a5b1 phagocytosis on
CamKII activation, we evaluated phagocytosis in untrans-
fected K562 cells which express a5b1, but not avb3. The ab-
sence of avb3 in these cells permitted the use of FN-coated
beads as a phagocytosis target for a5b1 rather than the
more selective mAb-16 beads used when avb3 is present.
K562 phagocytosis of FN-coated beads via a5b1 was inhib-
ited by the CamKII inhibitor KN62 (Fig. 5 B), but not the
control KN04. Thus, enhanced CamKII activity, initiated
by a5b1 binding of mAb-16 beads, appears to be required
for a5b1 phagocytosis.
These data support the hypothesis that ligation of a5b1
stimulates CamKII activity and that avb3-mediated sup-
pression of this activity is at least in part responsible for its
inhibition of a5b1-mediated phagocytosis. To demonstrate
that a similar mechanism was responsible for the inhibi-
tory b3 crosstalk to a5b1 during migration, we evaluated
the effects of the CamKII inhibitor KN62 on K562 cell mi-
gration in response to FN. KN62, but not the inactive ana-
logue KN04, inhibited the FN-induced migration of mock
transfected K562 cells and KTacb5 (Fig. 5 C). The pres-
ence of KN62 did not further attenuate the minimal migra-
tion of Kavb3 or KTacb3 cells.
Constitutively Active CamKII Overcomes
avb3-Inhibitory Integrin Crosstalk
To test the hypothesis that avb3 crosstalk to a5b1 was a re-
sult of CamKII downregulation by b3, K562 cells were in-
fected with an adenovirus-directing expression of a consti-
tutively active form of CamKII (1). Expression of this
construct in untransfected K562 cells resulted in an eight-
fold increase in CamKII activity over a control viral con-
struct encoding b-galactosidase (Fig. 6 A).
Next, KTacb3 and KTacb5 infected with virus encoding
either  b-galactosidase or constitutively active CamKII
were assayed for their ability to migrate in response to
FN. Expression of the active kinase specifically overcame
the constitutive inhibition of a5b1-mediated migration in
KTacb3, without any effect on migration in KTacb5 (Fig. 6
B). Thus, expression of active CamKII overcame avb3-
mediated suppression of a5b1 high affinity functions. Un-
fortunately, safety concerns precluded testing the effect of
the constitutively active CamKII in the phagocytosis assay.
Discussion
Integrin crosstalk is an important mechanism for coordi-
nating signals from multiple simultaneously ligated inte-
grins on a single cell for a functional response to extracel-
lular matrix. Although sometimes called “transdominant
inhibition,” crosstalk may induce, as well as suppress func-
tions of the target integrin, so we believe the more general
term, preferable (9). Although the number of examples of
integrin crosstalk has rapidly expanded in the past few
years, little is known concerning the molecular mecha-
nisms by which one integrin affects the function of an-
other. K562 cells have proved a valuable model for exami-
nation of integrin crosstalk because these cells express a
single integrin, a5b1, permitting a wide variety of genetic
experiments exploring the basis of integrin crosstalk. In
this system, we have previously shown that ligation of
transfected  avb3 inhibits the high affinity phagocytic func-
tion of a5b1 without effect upon low affinity a5b1-mediated
adhesion and that the b3 cytoplasmic tail is both neces-
sary and sufficient for this effect. We now have used this
model to explore the biochemical mechanisms involved
in crosstalk. Based on a previous report, we examined a
potential role for CamKII in avb3-mediated suppression of
the high affinity functions of a5b1, and performed struc-
Figure 6. Constitutively active CamKII reverses avb3 inhibitory
crosstalk. Untransfected K562 cells (A), or KTacb3 and KTacb5
(B) were infected with an adenovirus encoding either b-galac-
tosidase (AdCMV.gal) or a constitutively active form of CamKII
(AdCMV.CKIID3). CamKII activity against a synthetic sub-
strate was assayed in the presence and absence of calmodulin and
the CamKII inhibitor KN62 (2.5 mM) as described in Materials
and Methods and reported as the CamKII activity per mg of total
cellular protein (A). Migration of KTacb3 and KTacb5 expressing
either b-galactosidase or constitutively active CamKII to FN was
assessed as described in Materials and Methods (B). Shown are
mean 6 SEM of three determinations performed in triplicate.The Journal of Cell Biology, Volume 145, 1999 896
ture-function analysis of the b3 cytoplasmic tail to further
delineate the required structures for this unique signaling
event.
In this study, we show that either avb3 ligation or ex-
pression of the isolated b3 cytoplasmic tail exerts an inhib-
itory effect upon a5b1-mediated migration as well as
phagocytosis. Since both a5b1 migration and phagocytosis
are events that require the high affinity state of the inte-
grin, and since the avb3-mediated inhibition of a5b1 is re-
versed by KN62 in both cases, these data suggest that a
common signaling mechanism is responsible for these
crosstalk events.
Based on the data in this report, we propose the hypoth-
esis that CamKII, a ser/thr kinase with multiple intracellu-
lar substrates, is an important regulator of a5b1 function
and a target of integrin crosstalk. First, ligation of a5b1 by
specific antibody- or ligand-coated beads enhances the ac-
tivity of CamKII in both macrophages and K562 cells. Sec-
ond, activation of CamKII by ligation of a5b1 is required
for both phagocytosis and migration. In contrast CamKII
inhibitors do not affect adhesion which can be effected by
low affinity a5b1. Thus, the requirement for CamKII acti-
vation appears to be specific for the high affinity functions
of a5b1.
Coligation of avb3, or exposure of the isolated b3 cyto-
plasmic tail, prevents a5b1-induced rise in CamKII activ-
ity. Since the b3 integrin and the CamKII inhibitor have
the same effect on a5b1 function, the data suggest that sup-
pression of the ability of a5b1 to activate CamKII may be
an important mechanism of integrin crosstalk. A role for
CamKII suppression in integrin crosstalk is supported by
the reversal of crosstalk inhibition of migration with con-
stitutively active CamKII. Thus, our data support the hy-
pothesis that a5b1-mediated CamKII activation is required
for the high affinity functions of migration and phagocyto-
sis and that avb3-activated crosstalk suppresses these func-
tions through inhibition of CamKII activation. Thus, a5b1
and avb3 have opposing effects on CamKII activity.
Neither the upstream events regulating CamKII nor its
downstream effector are yet known. Tyrosine kinase in-
hibitors have no effect either on the high-affinity functions
of a5b1 or on suppression by avb3, suggesting the possibil-
ity that the entire pathway is independent of the well-
known effects of integrin ligation on several tyrosine ki-
nases (2, 3). Indeed, the independence of integrin crosstalk
from the phosphorylation of Tyr747 further suggests that
the signaling involved in the regulation of CamKII may be
completely independent of these pathways. A recent re-
port by Wu et al. (25) demonstrates that ligation of a5b1
and avb3 have opposite effects on plasma membrane cal-
cium channel activity. Since calcium is an important regu-
lator of CamKII, this voltage gated calcium channel may
be important in the differential regulation of CamKII by
these two integrins. Based on our preliminary pharmaco-
logic data, one likely effector for CamKII in a5b1 high
affinity function is myosin light chain kinase (MLCK).
MLCK inhibitors KT5926 and ML9 both reverse avb3
inhibition of a5b1-mediated phagocytosis and migration
without affecting inhibition of CamKII activation by avb3
ligation (Blystone, S.D., and E.J. Brown, unpublished
data). MLCK phosphorylation by CamKII is known to in-
hibit MLCK activity, leading presumably to decreased
myosin-induced cell traction (21). This integrin-mediated
modulation of myosin function is consistent with the
known role for myosin in phagocytosis and migration.
Analysis of structural requirements in the b3 cytoplas-
mic tail in avb3-mediated crosstalk reveals that Ser752 of
the b3 cytoplasmic tail is required for inhibition of CamKII
and for initiation of integrin crosstalk, while crosstalk is in-
dependent of either of the b3 cytoplasmic tail tyrosines.
The requirement for b3 Ser752 in crosstalk is unexpected.
The importance of Ser752 was suggested by a mutation to
proline in a patient with Glanzmann’s Thrombasthenia
which abolished high affinity binding of fibrinogen by
platelet  aIIbb3 (6, 8). However, detailed analysis has shown
that mutation of Ser752 to Ala does not affect ligand bind-
ing by aIIbb3 (8). The failure of the Ser752 to Ala b3 muta-
tion to affect ligand binding is supported by our studies in
K562 which demonstrate normal adhesion, normal migra-
tion (Fig. 2, B and C), and normal generation of the
ligand-induced binding site (LIBS) recognized by the anti-
body LIBS-1 in response to RGD peptide in this mutant
(data not shown). In contrast, integrin crosstalk is entirely
abolished by the S752A mutation, as it is by mutation to
Pro (the original Glanzmann’s mutation), to Glu (to mimic
a potential phosphorylation), and to Cys (as a conservative
mutation). Thus, it appears that Ser is absolutely required
at this position. While this suggests the possibility of Ser
phosphorylation in integrin crosstalk, we have been un-
able to demonstrate such phosphorylation so far. In con-
trast, Tyr747, which is absolutely required for stimulated
adhesion and for avb3-mediated migration (Fig. 1) in K562
cells, is not involved in integrin crosstalk. Thus, these two
amino acids, closely spaced in the relatively short cytoplas-
mic domain of one chain of an integrin, mediate two en-
tirely distinct signaling cascades.
In a recent report, Bouvard et al. (5) showed that in-
creased CamKII levels resulted in a decrease in the affin-
ity of a5b1 for FN. In this in vitro system, CamKII and the
phosphatase calcineurin regulate a5b1 affinity. Because
the  b3 suppression of a5b1 phagocytosis occurs subsequent
to a5b1 binding of ligand (3), it is possible that repeated cy-
cling of a5b1 affinity is required for phagocytosis and mi-
gration. Binding of ligand-coated beads to high affinity
a5b1 would activate CamKII, which would then decrease
integrin affinity. This hypothesis predicts that integrin
crosstalk from avb3 which blocks CamKII activation would
prevent a5b1 movement to the low affinity state. This is en-
tirely consistent with reports of receptor activation rather
than inactivation by integrin crosstalk (14, 24) which mea-
sured ligand binding rather than functions that require af-
finity modulation.
Finally, these data demonstrate that, while increased
CamKII activity is required for a5b1-mediated phagocyto-
sis and migration, avb3 can perform these same functions
independent of any increase in CamKII. This is a startling
example of the diversity of signaling and function among
the integrins. It suggests that there may be fundamental
differences within this family of closely related receptors
in how they mediate even their most basic functions.
While many studies have emphasized common features of
integrin a- and b-chains in association with cytoskeleton,
calreticulin, and signaling molecules, the differences be-
tween avb3 and a5b1 in requirements for phagocytosis andBlystone et al. Integrin Crosstalk 897
migration suggest that there will be profound differences
among integrins even as they perform similar functions.
The authors wish to thank all contributors of cDNAs and antibodies used
in these studies and the members of the Brown laboratory for suggestions
and advice on the performance of these studies. 
S.D. Blystone is an investigator of the Arthritis Foundation. This work
was supported by grants AI24674 and GM38330 from the National Insti-
tutes of Health to E.J. Brown. During these studies, S.D. Blystone was a
recipient of NRSA AI08990-02 and a grant from the Lucille P. Markey
Foundation.
Received line for publication 30 April 1998 and in revised form 8 March
1999.
References
1. Bilato, C., K. Curto, R.E. Monticone, R.R. Pauly, A.J. White, and M.T.
Crow. 1997. The inhibition of vascular smooth muscle cell migration by
peptide and antibody agonists of the av/b3 integrin complex is reversed
by activated calcium/calmodulin-dependent protein kinase II. J. Clin. In-
vest. 100:693–704.
2. Blystone, S.D., I.L. Graham, F.P. Lindberg, and E.J. Brown. 1994. Integrin
aV/b3 differentially regulates adhesive and phagocytic functions of the fi-
bronectin receptor av/b1. J. Cell Biol. 127:1129–1137.
3. Blystone, S.D., F.P. Lindberg, S.E. LaFlamme, and E.J. Brown. 1995. Inte-
grin  b3 cytoplasmic tail is necessary and sufficient for regulation of
alpha5/beta1 phagocytosis by aV/b3 and integrin associated protein. J.
Cell Biol. 130:745–754.
4. Blystone, S.D., M.P. Williams, S.E. Slater, and E.J. Brown. 1997. Require-
ment of integrin b3 tyrosine 747 for b3 tyrosine phosphorylation and reg-
ulation of aV/b3 avidity. J. Biol. Chem. 272:28757–28761.
5. Bouvard, D., A. Molla, and M.R. Block. 1998. Calcium/calmodulin-depen-
dent protein kinase II controls a5/b1 integrin-mediated inside-out signal-
ing. J. Cell Sci. 111:657–665.
6. Chen, Y.-P., I. Djaffar, D. Pidard, B. Steiner, A.-M. Cieutat, J.P. Caen, and
J.-P. Rosa. 1992. Ser-752®Pro mutation in the cytoplasmic domain of in-
tegrin b3 subunit and defective activation of platelet integrin aIIbb3 (gly-
coprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc.
Natl. Acad. Sci. USA. 89:10169–10173.
7. Chen, Y.-P., T.E. O’Toole, T. Shipley, J. Forsyth, S.E. LaFlamme, K.M.
Yamada, S.J. Shattil, and M.H. Ginsberg. 1994. “Inside-out” signal trans-
duction inhibited by isolated integrin cytoplasmic domains. J. Biol.
Chem. 269:18307–18310.
8. Chen, Y.-P., T.E. O’Toole, J. Ylänne, J.-P. Rosa, and M.H. Ginsberg. 1994.
A point mutation in the integrin b3 cytoplasmic domain (S752®P) impairs
bidirectional signaling through aIIbb3 (platelet glycoprotein IIb-IIIa).
Blood. 84:1857–1865.
9. Diaz-Gonzalez, F., J. Forsyth, B. Steiner, and M.H. Ginsberg. 1996. Trans-
dominant inhibition of integrin function. Mol. Biol. Cell. 7:1939–1951.
10. Gresham, H.D., J.L. Goodwin, D.C. Anderson, and E.J. Brown. 1989. A
novel member of the integrin receptor family mediates Arg-Gly-Asp-
stimulated neutrophil phagocytosis. J. Cell Biol. 108:1935–1943.
11. Huhtala, P., M.J. Humphries, J.B. McCarthy, P.M. Tremble, Z. Werb, and
C.H. Damsky. 1995. Cooperative signalling by alpha5/beta1 and alpha4/
beta1 integrins regulates metalloproteinase gene expression in fibro-
blasts adhering to fibronectin. J. Cell Biol. 129:867–879.
12. Hunt, T.K., D.R. Knighton, K.K. Thakral, W.H. Goodson, and W.S. An-
drews. 1984. Studies on inflammation and wound healing: Angiogenesis
and collagen synthesis stimulated in vivo by resident and activated
wound macrophages. Surgery. 96:48–54.
13. Hynes, R.O. 1992. Integrins: Versatility, modulation, and signaling in cell
adhesion. Cell. 69:11–25.
14. Ishibashi, Y., S. Claus, and D.A. Relman. 1994. Bordetella pertussis fila-
mentous hemagglutinin interacts with a leukocyte signal transduction
complex and stimulates bacterial adherence to monocyte CR3 (CD11b/
CD18). J. Exp. Med. 180:1225–1233.
15. Pacifici, R., J. Roman, R. Kimble, R. Civitelli, C.M. Brownfield, and C.
Bizzarri. 1994. Ligand binding to monocyte a5/b1 integrin activates the
a2/b1 receptor via the a5 subunit cytoplasmic domain and protein kinase
C. J. Immunol. 153:2222–2233.
16. Pijuan-Thompson, V., and C.L. Gladson. 1997. Ligation of integrin a5/b1 is
required for internalization of vitronectin by integrin aV/b1.  J. Biol.
Chem. 272:2736–2743.
17. Porter, J.C., and N. Hogg. 1997. Integrin cross talk: activation of lympho-
cyte function-associated antigen-1 on human T cells alters a4/b1- and
a5/b1-mediated function. J. Cell Biol. 138:1437–1447.
18. Ruoslahti, E. 1991. Integrins. J. Clin. Invest. 87:1–5.
19. Senior, R.M., H.D. Gresham, G.L. Griffin, E.J. Brown, and A.E. Chung.
1992. Entactin stimulates neutrophil adhesion and chemotaxis through
interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte
response integrin (LRI). J. Clin. Invest. 90:2251–2257.
20. Simon, K.O., E.M. Nutt, D.G. Abraham, G.A. Rodan, and L.T. Duong.
1997. The a2/b1 integrin regulates a5/b1-mediated cell migration toward
fibronectin. J. Biol. Chem. 272:29380–29389.
21. Tansey, M.G., R.A. Word, H. Hidaka, H.A. Singer, C.M. Schworer, K.E.
Kamm, and J.T. Stull. 1992. Phosphorylation of myosin light chain kinase
by the multifunctional calmodulin-dependent kinase II in smooth muscle
cells. J. Biol. Chem. 267:12511–12516.
22. Turner, C.E., and J.T. Miller. 1994. Primary sequence of paxillin contains
putative SH2 and SH3 domain binding motifs and multiple LIM do-
mains: identification of a vinculin and pp125FAK binding region. J. Cell
Sci. 107:1583–1591.
23. van Kooyk, Y., E. Van de Wiel-van Kemenade, P. Weder, R.J.F. Huijbens,
and C.G. Figdor. 1993. Lymphocyte function-associated antigen 1 domi-
nates very late antigen 4 in binding of activated T cells to endothelium. J.
Exp. Med. 177:185–190.
24. Van Strijp, J.A.G., D.G. Russell, E. Tuomanen, E.J. Brown, and S.D.
Wright. 1993. Ligand specificity of purified complement receptor type 3
(CD11b/CD18, Mac-1, aM b2): indirect effects of an Arg-Gly-Asp se-
quence. J. Immunol. 151:3324–3336.
25. Wu, X., J.E. Mogford, S.H. Platts, G.E. Davis, G.A. Meininger, and M.J.
Davis. 1998. Modulation of calcium currents in arteriolar smooth muscle
by aV/b3 and a5/b1 integrin ligands. J. Cell Biol. 143:241–252.
26. Zhou, M.J., D.M. Lublin, D.C. Link, and E.J. Brown. 1995. Distinct ty-
rosine kinase activation and Triton X-100 insolubility upon FcRII or
FcRIIIB ligation in human polymorphonuclear leukocytes. J. Biol.
Chem. 270:13553–13560.